Virginia Commonwealth University/Massey Cancer Center
Clinical research site in Richmond, Virginia · 520 N 12TH ST, LYONS BUILDING, ROOM 456, RICHMOND, VA 23298-0566 · (804) 828-7978
As of September 2026, 33 paid clinical trials are recruiting at Virginia Commonwealth University/Massey Cancer Center in Richmond, Virginia. Active studies at this site cover conditions such as B-cell Malignancy, Cervical Cancer and Chemotherapy-induced Peripheral Neuropathy. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Virginia Commonwealth University/Massey Cancer Center (33)
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1
Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT31-1 for Treating ARDS
A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD)
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
Endocardial Mapping With the CoreMap EP Mapping System
Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer
A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
Comparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy
Behavioral Exercise Training to Reduce Cardiovascular Disease Risk
A Study of Emapalumab for Pediatric Aplastic Anemia
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Get new-trial alerts for Virginia Commonwealth University/Massey Cancer Center
We'll email you whenever a new clinical trial starts recruiting at this research site in Richmond, VA. Unsubscribe anytime.
More research sites in Richmond
- Virginia Commonwealth University (159 trials)
- VCU Massey Comprehensive Cancer Center (106 trials)
- VCU Massey Cancer Center at Stony Point (51 trials)
- Virginia Cancer Institute (23 trials)
- Bon Secours Saint Mary's Hospital (23 trials)
- Bon Secours Cancer Institute at Reynolds Crossing (18 trials)
- Clinical Research Partners, LLC (13 trials)
- Bon Secours Richmond Community Hospital (12 trials)
- VCU Medical Center (9 trials)
- Virginia Commonwealth University Massey Cancer Center (9 trials)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.
Explore more
Paid clinical trials in Richmond, VA · Virginia clinical trials